Clinical Evaluation of the Efficacy of a Dietary Supplement Claiming Anti-aging Properties and UV-protection

Inclusion Criteria: * Healthy female subjects * Caucasian ethnicity * Age between 35 and 65 years old (extremes included) * Phototype I to III (with all skin types without any specific repartition) * Visible Crow's feet wrinkles (\> 2 according to Skin Aging Atlas - Caucasian Type - Bazin Roland) and mild to moderate skin slackness at cheek level (grade 1-3 - internal clinical scale) * Subjects who have not been recently involved in any other similar study (at least 1 month of wash-out) * Subjects registered with health social security or health social insurance * Subjects having signed the Informed Consent Form (ICF) and Privacy Policy for their participation in the study and a photograph authorization * Subjects able to understand the language used in the investigation center and the information given * Subjects able to comply with the protocol and follow protocol constraints and specific requirements * Willingness to use during all the study period only the product to be tested * Willingness not to use similar products that could interfere with the expected product effect to be tested (e.g. with antiaging or soothing or UV protection efficacy) * Willingness to not vary the normal daily routine (i.e. lifestyle, physical activity, diet etc.) * Subjects under effective contraception (oral/not oral) if women of childbearing potential; not expected to be changed during the trial * Subjects who have not sun exposure (both natural or artificial) for at least two months * Subjects who accept not to expose in intensive way to UV rays during the whole study duration * Subjects who have not been involved in any sun test (for SPF evaluation) or tests that provide skin irradiation since less than two months Exclusion Criteria: * Subject is taking part or planning to participate to another clinical study in the same or in another investigation center * Subject who is deprived of freedom by administrative or legal decision or under guardianship * Subject admitted in a sanitary or social facilities * Subject who is planning an hospitalization during the study * Subjects under treatment with food supplements which could interfere with the functionality of the product under study * Subject breastfeeding, pregnant or not willing to take necessary precautions to avoid pregnancy during the study (if women of childbearing potential) * Subject has started or changed estrogen-progesterone contraception or hormonal treatment, within the 3 months prior to the study or foreseeing it for the duration of the study * Subject having an acute, chronic or progressive illness liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements * Subjects under radiotherapy, chemotherapy at any time * Subject having a skin condition liable to interfere with the study data or considered by the Investigator hazardous for the subject or incompatible with the study requirements * Pharmacological treatments (topic or systemic) known to interfere with skin metabolism/physiology * Subjects under locally pharmacological/non-pharmacological treatment applied on the skin area monitored during the test * Subject with known or suspected sensitization to one or more test formulation ingredients * Subjects considered as not adequate to participate to the study by the investigator * Adult protected by law (under control or hospitalized in public or private institutions for reasons other than research, or incarcerated) * Subjects not able to communicate or cooperate with the investigator for problems related to language, mental retardation or impaired brain function